<DOC>
	<DOCNO>NCT01085851</DOCNO>
	<brief_summary>Topical antihistamine use promote relief sunburn relate symptom ( erythema , itch burning sensation ) . Dexchlorpheniramine maleate 1 % cream topical antihistamine formulation approve ANVISA Brazil relief skin irritation pruritus , include one cause sunburn . The aim present study demonstrate non-inferiority new pharmacological preparation dexchlorpheniramine maleate ( 1 % lotion ) standard preparation ( 1 % cream ) relief sunburn relate symptom demonstrate safety preparation .</brief_summary>
	<brief_title>Non-inferiority Clinical Trial Dexchlorpheniramine ( Cream Versus Lotion ) Relief Sunburn Related Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Sunburn</mesh_term>
	<mesh_term>Dexchlorpheniramine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<criteria>Signs solar erythema mild moderate intensity result voluntary exposure sun within last 72 hour Presence lesion degree symmetry allow comparison pharmaceutical formulation Compliance subject treatment protocol Agreement term inform consent participant legal guardian young 18 year old Pregnancy risk pregnancy Lactation Signs solar erythema severe intensity Use topical systemic antiinflammatory , antihistamine immunosuppressive drug within last 48 hour prior study History atopy allergic diseases History allergy component formulation Other condition consider investigator reasonable noneligibility</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Sunburn</keyword>
	<keyword>Dexchlorpheniramine</keyword>
	<keyword>Lotion</keyword>
	<keyword>Cream</keyword>
</DOC>